Meropenem
DOSAGE FORM:
Dry Powder for Solution for Injection.
STORAGE:
Store at below 30′ C. Protect from light.
INDICATIONS:
Meropenem is indicated for all age group including infants above 3 months of age as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms:
- Pneumonias and Nosocomial Pneumonias
- Urinary Tract Infections
- Intra-abdominal Infections
- Gynecological Infections, such as endometritis and pelvic inflammatory disease
- Skin and Skin Structure Infections
- Meningitis
- Septicemia
- Empiric treatment, for presumed infection in adult patients with febrile neutropenia, used as monotherapy or in combination with antiviral or antifungal agents.
COMPOSITION
Each vial contains:
Sterile Meropenem Trihydrate USP
Equivalent to Anhydrous Meropenem…………..1 gm / 500 mg / 250 mg /125 mg
Sterile Sodium Carbonate USP
Equivalent to Sodium…………90.2 mg/45.1 mg/22.55 mg/11.275 mg
Sterile Meropenem Trihydrate USP
Equivalent to Anhydrous Meropenem…………..1 gm / 500 mg / 250 mg /125 mg
Sterile Sodium Carbonate USP
Equivalent to Sodium…………90.2 mg/45.1 mg/22.55 mg/11.275 mg
METHOD OF ADMINISTRATION
It can be given as an intravenous bolus injection over approximately 5 minutes or by intravenous infusion over approximately 15 to 30 minutes using specific available diluents.
CONTRAINDICATIONS
It is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams.
